March 2008 Volume 11 Number 1, pp 1 - 105
---------------------------------------------------------------------
Celebrating 20 years of excellence in cancer research
Oncogene is published weekly and covers the structure and function of
oncogenes. Oncogene publishes a series of review issues -- Oncogene
Reviews, which take a closer look into the most current research and
advances that are impacting the study of cancer. Visit
http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BXuC0Ej
to read a full FREE issue.
http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0VT50Eo
---------------------------------------------------------------------
Articles for Prostate Cancer and Prostatic Diseases are published
online ahead of print through Advance Online Publication (AOP),
meaning that the latest research reaches you in the timeliest way
possible. Check http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0Ba240EW each
week to make sure that you are not left behind.
----------------------
EDITORIAL
----------------------
Report from Durham
J W Moul
http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUR0Eo
----------------------
RESEARCH HIGHLIGHTS
----------------------
Prostate News
http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUS0Ep
----------------------
REVIEWS
----------------------
Soy isoflavone genistein in prevention and treatment of prostate cancer
F G E Perabo, E C Von Low, J Ellinger, A von Rucker, S C Muller and P J Bastian
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUT0Eq
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUU0Er
Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates
T J Polascik
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUV0Es
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUW0Et
Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia
G Godoy and S S Taneja
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUX0Eu
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUY0Ev
Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells
J Miki and J S Rhim
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUZ0Ew
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUa0E4
----------------------
ORIGINAL ARTICLES
----------------------
Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer
J L Chin, C-K Ng, N J Touma, N J Pus, R Hardie, M Abdelhady, G Rodrigues, J Radwan, V Venkatesan, M Moussa, D B Downey and G Bauman
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUb0E5
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUc0E6
Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer
N Fleshner, T E Keane, C A Lawton, P F Mulders, H Payne, S S Taneja and T Morris
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUd0E7
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUe0E8
Antidepressants and risk of prostate cancer: a nested case - control study
H M Tamim, S Mahmud, J A Hanley, J-F Boivin, M R Stang and J-P Collet
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUf0EA
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUg0EB
Fruit, vegetable, vitamin A intakes, and prostate cancer risk
G L Ambrosini, N H de Klerk, L Fritschi, D Mackerras and B Musk
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUh0EC
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUi0ED
Quality of life in young men after radical prostatectomy
J L Wright, D W Lin, J E Cowan, P R Carroll and M S Litwin
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUj0EE
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUk0EF
Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience
M Manoharan, R Ayyathurai, A M Nieder and M S Soloway
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUl0EG
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUm0EH
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis
A Horiguchi, D Y T Chen, O B Goodman, R Zheng, R Shen, H Guan, L B Hersh and D M Nanus
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUn0EI
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUo0EJ
The influence of [alpha]1-antagonist on the expression pattern of TNF receptor family in primary culture of prostate epithelial cells from BPH patients
T Drewa, Z Wolski, B Misterek, R Debski and J Styczynski
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUp0EK
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUq0EL
Association between FAS polymorphism and prostate cancer development
L Lima, A Morais, F Lobo, F M Calais-da-Silva, F E Calais-da-Silva and R Medeiros
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUr0EM
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUs0EN
----------------------
CASE REPORTS
----------------------
PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy
M Gacci, S Serni, A Lapini, G Vittori, G Vignolini, G Nesi and M Carini
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUt0EO
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUu0EP
The treatment of chyluria secondary to advanced carcinoma of the prostate
S A Cluskey, A Myatt and M A Ferro
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUv0EQ
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BnUw0ER
---------------------------------------------------------------------
Molecular Therapy is accepting submissions!
Featuring author benefits like ZERO submission fees, Advanced Online
Publication (AOP), and inclusion in abstracting and indexing services
like ISI, MEDLINE and EMBASE. Molecular Therapy is the only journal
ranked within the top 15th percentile in biotechnology, genetics and
medicine. To learn more about publishing in Molecular Therapy visit
http://ealerts.nature.com/cgi-bin24/DM/y/ejA30Xztnp0Hjl0BHKr0EY .
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
